Exogenous bone marrow derived-putative endothelial progenitor cells attenuate ischemia reperfusion-induced vascular injury and renal fibrosis in mice dependent on pericytes

Theranostics. 2020 Oct 25;10(26):12144-12157. doi: 10.7150/thno.48562. eCollection 2020.

Abstract

Rationale: Capillaries are composed of endothelial cells and the surrounding mural cells, pericytes. Microvascular repair after injury involves not only the proliferation of endothelial cells but also pericyte-based vessel stabilization. Exogenous bone marrow derived-putative endothelial progenitor cells (b-pEPCs) have the potential for vascular repair; however, their effect on vascular structure stabilization and pericyte-related pathobiological outcomes in the injured kidney has not been fully examined. Methods: We applied ischemia-reperfusion (IR) to induce renal vascular injury and renal fibrosis in mice. Platelet-derived growth factor receptor β (PDGFR-β)-DTR-positive mice were generated to deplete pericytes, and exogenous b-pEPCs and the PDGFR-β ligand, PDGF chain B (PDGF-BB), were employed to explore the relationship among b-pEPCs, pericytes, vascular repair, and early renal fibrosis. Results: Administration of b-pEPCs reduced IR-induced pericyte-endothelial detachment, pericyte proliferation, and myofibroblast transition via a paracrine mode, which preserved not only vascular stabilization but also ameliorated IR-initiated renal fibrosis. PDGF-BB upregulated the expression of PDGFR-β, exacerbated vascular abnormality, and pericyte-myofibroblast transition, which were ameliorated by b-pEPCs administration. The exogenous b-pEPCs and their culture medium (CM) induced vascular injury protection, and renal fibrosis was blocked by selective deletion of pericytes. Conclusion: Exogenous b-pEPCs directly protect against IR-induced vascular injury and prevent renal fibrosis by inhibiting the activation of PDGFR-β-positive pericytes.

Keywords: PDGF-BB/PDGFR-β; pEPCs; pericyte; renal fibrosis.; vascular injury.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Kidney Injury / pathology
  • Acute Kidney Injury / prevention & control*
  • Animals
  • Becaplermin / administration & dosage
  • Becaplermin / metabolism
  • Cell Proliferation
  • Disease Models, Animal
  • Endothelial Progenitor Cells / transplantation*
  • Fibrosis
  • Humans
  • Injections, Intraperitoneal
  • Kidney / blood supply
  • Kidney / pathology*
  • Male
  • Mice
  • Myofibroblasts / pathology
  • Parabiosis
  • Paracrine Communication
  • Pericytes / pathology*
  • Proteins
  • Receptor, Platelet-Derived Growth Factor beta / metabolism
  • Reperfusion Injury / pathology
  • Reperfusion Injury / prevention & control*

Substances

  • Proteins
  • WFDC12 protein, human
  • Becaplermin
  • Receptor, Platelet-Derived Growth Factor beta